Step 1 topics → Hematology and Oncology → Inherited Platelet Function Disorders

Inherited Platelet Function Disorders

USMLE Step 1 trap: Confuses the specific glycoprotein defect in Bernard-Soulier vs Glanzmann thrombasthenia. Bernard-Soulier lacks GPIb (adhesion defect, no vWF binding) while Glanzmann lacks GPIIb/IIIa (aggregation defect, no fibrinogen binding).

Inherited platelet function disorders are a low-yield but high-clarity topic on USMLE Step 1 — the exam essentially reduces this to one comparison: Bernard-Soulier syndrome versus Glanzmann thrombasthenia. Both cause mucocutaneous bleeding with a prolonged bleeding time and normal PT/PTT/platelet count, but they differ in mechanism, platelet size, and aggregation pattern. The most common wrong assumption: that Bernard-Soulier fails all aggregation agonists. It doesn't — only ristocetin fails, because GPIb (the absent receptor) mediates vWF-dependent adhesion, not aggregation. All other agonists work normally in Bernard-Soulier. It's Glanzmann thrombasthenia (GPIIb/IIIa absent) where all aggregation agonists fail but ristocetin is spared. That reversal is exactly what the exam tests.

The way USMLE Step 1 tests this is almost always differential-style: a clinical vignette describes a patient with bleeding symptoms and abnormal lab results, then asks you to identify the defect or explain why a specific aggregation study is abnormal. The tricky part isn't memorizing the names — it's knowing which glycoprotein does what and how that maps onto the ristocetin aggregation test. Students who just memorize 'GPIb = Bernard-Soulier' without understanding that GPIb mediates vWF-dependent adhesion (not aggregation) will get burned on a question asking why ristocetin specifically fails.

The three misconceptions that consistently trip students up are: (1) confusing which glycoprotein is defective in each disorder, (2) misapplying the ristocetin aggregation result — particularly assuming Bernard-Soulier fails all agonists when it only fails ristocetin — and (3) forgetting that Bernard-Soulier shows giant platelets on peripheral smear while Glanzmann does not. Platelet size on smear is a classic exam discriminator that students miss because they focus on aggregation and ignore morphology.

From real student decks
78%have cards covering this topic
65%have mature cards
1median lapses in 14 days

Common misconceptions

Common mistake
Wrong: Both Bernard-Soulier and Glanzmann thrombasthenia involve defects in the same glycoprotein complex.
Right: Bernard-Soulier lacks GPIb (adhesion defect, no vWF binding) while Glanzmann lacks GPIIb/IIIa (aggregation defect, no fibrinogen binding).
Bernard-Soulier and Glanzmann affect different steps of platelet plug formation and therefore different glycoproteins entirely. GPIb is the receptor that tethers platelets to vWF on damaged subendothelium — this is adhesion, the first step. GPIIb/IIIa is the receptor that crosslinks platelets to each other via fibrinogen — this is aggregation, the second step. Confusing them means you'll misinterpret any question that asks about the mechanism of the defect or why a specific agonist fails.
Common mistake
Wrong: Both disorders show absent aggregation with all agonists including ristocetin.
Right: Glanzmann shows absent aggregation with all agonists except ristocetin, while Bernard-Soulier shows absent aggregation with ristocetin only (normal with ADP, collagen, thrombin).
Ristocetin is the key discriminator here and it works by mimicking vWF-mediated platelet adhesion via GPIb. In Bernard-Soulier, GPIb is absent, so ristocetin fails — but all other agonists (ADP, collagen, thrombin) work fine because aggregation via GPIIb/IIIa is intact. In Glanzmann, GPIIb/IIIa is absent, so all aggregation agonists fail — but ristocetin still works because adhesion via GPIb is intact. The pattern is opposite, and the exam will test whether you know which disorder spares ristocetin versus which one is spared by ristocetin.
Common mistake
Wrong: Platelet size is normal in both Bernard-Soulier and Glanzmann thrombasthenia.
Right: Bernard-Soulier shows giant platelets on smear, while Glanzmann shows normal platelet size.
Platelet size is a direct clue embedded in the CBC or peripheral smear description, and it only points one direction: giant platelets mean Bernard-Soulier. The reason is that GPIb plays a structural role in platelet membrane organization during megakaryocyte fragmentation — without it, platelets are released in abnormally large forms. Glanzmann affects GPIIb/IIIa, which has no role in platelet sizing, so morphology is normal. If a vignette mentions large platelets and you're not immediately thinking Bernard-Soulier, you're missing the discriminator.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Given a patient's clinical presentation, lab results (bleeding time, platelet count, PT/PTT), and platelet aggregation study results, correctly identify whether the defect is Bernard-Soulier (GPIb deficiency) or Glanzmann thrombasthenia (GPIIb/IIIa deficiency) — and explain the mechanism behind the abnormal result.

Can you avoid these mistakes?

A 16-year-old girl has recurrent nosebleeds and heavy menstrual periods. Her bleeding time is prolonged, platelet count is normal, and PT/PTT are normal. Platelet aggregation studies show absent aggregation with ADP, collagen, and thrombin, but normal aggregation with ristocetin. Peripheral smear shows normal platelet size. What is the deficient protein, and what step of hemostasis does it mediate?
A similar patient has the same bleeding history and labs, but aggregation is normal with ADP and collagen and absent only with ristocetin. The smear shows large platelets. What is the diagnosis, and why does ristocetin specifically fail in this condition?
A question stem describes a patient with a platelet function disorder and asks which aggregation agonist will give a NORMAL result in Glanzmann thrombasthenia. What is your answer and why?
Two patients have identical presentations — prolonged bleeding time, normal platelet count, normal PT/PTT — but opposite platelet aggregation patterns. Patient A has absent aggregation with ADP and collagen but normal aggregation with ristocetin; her smear shows normal platelet size. Patient B has normal aggregation with ADP and collagen but absent aggregation with ristocetin; her smear shows giant platelets. Name the diagnosis for each, identify the deficient glycoprotein, and explain why each patient has their specific ristocetin result.

Related topics

Platelet Physiology and Primary Hemostasis Hematopoiesis and Lineage Differentiation RBC Physiology and Lifespan WBC Differential and Function

See how your Anki deck covers this topic.

Upload your deck for a free audit →